Northern Trust Portfolio holdings
Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$335M |
| 2 |
Amazon
AMZN
|
+$287M |
| 3 |
Otis Worldwide
OTIS
|
+$260M |
| 4 |
Alibaba
BABA
|
+$245M |
| 5 |
FlexShares iBoxx 3-Year Target Duration TIPS Index Fund
TDTT
|
+$237M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$720M |
| 2 |
FlexShares Global Upstream Natural Resources Index Fund
GUNR
|
+$365M |
| 3 |
RTN
Raytheon Company
RTN
|
+$357M |
| 4 |
Schwab US Broad Market ETF
SCHB
|
+$212M |
| 5 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$162M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.87% |
| 2 | Healthcare | 13.57% |
| 3 | Financials | 12.24% |
| 4 | Consumer Discretionary | 10.73% |
| 5 | Communication Services | 8.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2751
West Bancorporation
WTBA
$484M
| $3.42M | ﹤0.01% |
195,580
+2,250
| +1% | +$38.8K |
|
|
PFNX
2752
DELISTED
Pfenex Inc.
PFNX
| $3.42M | ﹤0.01% |
409,426
+36,472
| +10% | +$273K |
|
2753
Hingham Institution for Saving
HIFS
$658M
| $3.41M | ﹤0.01% |
20,326
+1,077
| +6% | +$167K |
|
2754
KRONOS Worldwide
KRO
$709M
| $3.41M | ﹤0.01% |
327,318
-17,234
| -5% | -$162K |
|
|
CBPO
2755
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $3.4M | ﹤0.01% |
33,313
-5,119
| -13% | -$548K |
|
|
UBX
2756
DELISTED
Unity Biotechnology
UBX
| $3.4M | ﹤0.01% |
39,183
+6,167
| +19% | +$457K |
|
2757
iShares ESG Optimized MSCI USA ETF
SUSA
$4.14B
| $3.4M | ﹤0.01% |
50,758
| – | – |
|
|
SLCA
2758
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $3.39M | ﹤0.01% |
939,271
-36,364
| -4% | -$91.8K |
|
|
ORBC
2759
DELISTED
ORBCOMM, Inc.
ORBC
| $3.39M | ﹤0.01% |
879,836
-53,380
| -6% | -$159K |
|
2760
Vanguard FTSE Pacific ETF
VPL
$8.33B
| $3.38M | ﹤0.01% |
53,037
+1,487
| +3% | +$89.7K |
|
2761
Donegal Group Class A
DGICA
$715M
| $3.37M | ﹤0.01% |
237,106
+90,578
| +62% | +$1.29M |
|
2762
Clarus
CLAR
$128M
| $3.36M | ﹤0.01% |
290,552
+5,666
| +2% | +$57.5K |
|
2763
Astrana Health
ASTH
$1.76B
| $3.35M | ﹤0.01% |
203,342
+53
| +0% | +$834 |
|
2764
Turkcell
TKC
$4.89B
| $3.35M | ﹤0.01% |
581,910
-80,092
| -12% | -$409K |
|
2765
Viemed Healthcare
VMD
$372M
| $3.31M | ﹤0.01% |
+344,330
| New | +$2.68M |
|
2766
Anavex Life Sciences
AVXL
$298M
| $3.3M | ﹤0.01% |
670,002
+51,645
| +8% | +$195K |
|
2767
Keros Therapeutics
KROS
$204M
| $3.29M | ﹤0.01% |
+87,655
| New | +$2.7M |
|
2768
Personalis
PSNL
$1.44B
| $3.29M | ﹤0.01% |
253,440
+53,236
| +27% | +$591K |
|
2769
Gates Industrial Corporation Ltd.
GTES
$7.57B
| $3.28M | ﹤0.01% |
318,595
-4,153
| -1% | -$37.7K |
|
2770
Citizens & Northern Corp
CZNC
$454M
| $3.27M | ﹤0.01% |
158,408
+14,472
| +10% | +$273K |
|
2771
Equity Bancshares
EQBK
$1.06B
| $3.27M | ﹤0.01% |
187,269
+7,855
| +4% | +$130K |
|
2772
Alico
ALCO
$283M
| $3.26M | ﹤0.01% |
104,718
+34,143
| +48% | +$1.02M |
|
2773
Compañía de Cervecerías Unidas
CCU
$2.19B
| $3.26M | ﹤0.01% |
227,841
-4,516
| -2% | -$64.9K |
|
2774
Verastem
VSTM
$508M
| $3.26M | ﹤0.01% |
157,930
+134,990
| +588% | +$3.57M |
|
2775
Purple Innovation
PRPL
$43.2M
| $3.26M | ﹤0.01% |
7,240
+2,561
| +55% | +$808K |
|
Similar funds
Northern Trust's Q2 2020 Portfolio in Review
As of Q2 2020, Northern Trust held 4,386 positions worth $422B, up 21% from $348B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Northern Trust's Q2 2020 filing shows 169 new, 2,281 increased, 1,710 reduced and 126 closed positions. Its largest new stake was Otis Worldwide: 5,015,118 shares worth $285M. The largest sale was Allergan plc, an estimated $720M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- Northern Trust's largest Q2 2020 buy was Otis Worldwide: 5,015,118 shares worth $285M.
- Northern Trust added most to AbbVie in Q2 2020, an estimated $335M increase.
- Northern Trust's biggest Q2 2020 reduction was FlexShares Global Upstream Natural Resources Index Fund, cutting an estimated $365M.
- Northern Trust fully exited Allergan plc in Q2 2020, selling an estimated $720M.
- Northern Trust's ten largest holdings make up 21% of its $422B portfolio in Q2 2020.
- Northern Trust opened 169 new positions and closed 126 in Q2 2020.
- Northern Trust's portfolio value rose 21% quarter-over-quarter to $422B.
Based on Northern Trust's 13F filing for Q2 2020, filed 14 Aug 2020.